Skip to content
  • Tuesday, 27 October 2026
  • 11:14 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The oral exposure challenge in PROTACs: What drug developers need to solve early
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Oct 13, 2026 0

Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough in chemical biology to a validated clinical reality. In…

Read More
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Oct 5, 2026 0

Proteolysis Targeting Chimera (PROTAC) technology has officially transitioned from a visionary academic concept to a cornerstone of modern clinical pharmacology.…

Read More
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Sep 27, 2026 0

The landscape of modern pharmacology shifted fundamentally in May 2026 with the U.S. Food and Drug Administration’s approval of vepdegestrant,…

Read More
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Sep 20, 2026 0

The landscape of modern pharmacology shifted fundamentally in May 2026, when the U.S. Food and Drug Administration (FDA) granted approval…

Read More
Molecular & Cell Biology

Unveiling Adenomera varcena: A New Frog Species Highlights the Critical Need for Taxonomic Discovery in the Amazon Basin

Angie Faith Sep 18, 2026 0

In the dense, seasonally inundated forests of the western Amazon, a small, unassuming amphibian has emerged as a significant indicator…

Read More
Laboratory Automation & Robotics

The oral exposure challenge in PROTACs: What drug developers need to solve early

Lana Keisha Sep 12, 2026 0

Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough to a cornerstone of modern oncology, fundamentally altering how…

Read More
Pharmaceutical R&D

Advancements in Alzheimer’s Disease Research Highlight Need for Subtype-Specific Treatments and Equitable Access to Diagnostics

Teuku Ryan Jul 22, 2026 0

The landscape of Alzheimer’s disease (AD) research and treatment is undergoing a significant transformation, marked by the recent advent of…

Read More
Advanced Materials Science

Self-Regulating Artificial Photosynthesis System from Osaka Metropolitan University Eliminates Need for Batteries in Solar Fuel Production

Nila Kartika Wati Jun 28, 2026 0

In a significant advancement for the field of renewable energy and carbon capture, a research team at Osaka Metropolitan University…

Read More
Advanced Materials Science

Self-Regulating Artificial Photosynthesis System Developed by Osaka Metropolitan University Eliminates Need for Battery-Based Control Equipment

Nila Kartika Wati Jun 21, 2026 0

In a significant stride toward sustainable energy independence, a research team at Osaka Metropolitan University (OMU) has unveiled a pioneering…

Read More
Pharmaceutical R&D

Europe Faces a Decade-High Surge in Sexually Transmitted Infections, Highlighting Urgent Need for Enhanced Prevention and Treatment Strategies

Teuku Ryan May 23, 2026 0

New data released by Europe’s leading infectious disease agency reveals a concerning decade-high surge in bacterial sexually transmitted infections (STIs),…

Read More

Posts pagination

1 2
AACR 2026 Annual Meeting in San Diego to Highlight Precision Oncology and Integrated Therapies Under Co-Chairs Alice Shaw and Paul MischelTWiV 1284: Clinical Update with Dr. Daniel GriffinGroundbreaking Study Reveals Human Heart Muscle Can Regenerate, Offering Hope for Heart Failure CuresGraphEval: A Knowledge Graph-Based Framework Revolutionizes LLM Hallucination Detection and Explainability
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ